glp-1 pfizer ADA '26: Lilly's dominance, Pfizer's 'foundational' drug and Roche's 'me-too' option Pfizer discontinues oral GLP-1 receptor

Use licensed prescribers and legitimate pharmacies

Join the many health-conscious individuals across the United States who trust us for their CJC-1295+ipamorelin supplementation needs

While OEA might support weight management, its not a one-to-one swap for something like Ozempic or Mounjaro

Hence an approval in the next one-and-a-half to two years seems unlikely." Chereddi adds, "Hengrui's product is just starting Phase 3 in China, and Innovent's product has approval from the Chinese FDA, but hasn't been filed in India." His conclusion: "Indian generic manufacturers face a limited but real opportunitynot an open market." Shah frames it as a "timing risk, not an inevitability", and flags three gating factors beyond trial requirements: Regulatory scrutiny of novel oral delivery systems, bioavailability concerns specific to Indian populations and intellectual property protection on oral peptide platforms that limits immediate generic replication

Research looks into its use for peripheral neuropathy, multiple sclerosis-related pain, and other nerve damage